Osteopontin regulates anabolic effect in human menopausal osteoporosis with intermittent parathyroid hormone treatment (Q84794142)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734029%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Osteopontin regulates anabolic effect in human menopausal osteoporosis with intermittent parathyroid hormone treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734029%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

T-I Chiang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734029%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

I-C Chang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734029%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

H-S Lee

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734029%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

H Lee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734029%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

C-H Huang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734029%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Y-W Cheng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734029%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

24 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734029%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis International

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734029%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734029%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

577-585

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734029%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734029%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00198-010-1327-x

11 February 2020

exact match

0 references

cites work

RANK, RANKL and osteoprotegerin in arthritic bone loss

1 reference

12 December 2020

Interaction of osteopontin with osteoclast integrins

1 reference

12 December 2020

Increased serum osteopontin is a risk factor for osteoporosis in menopausal women

1 reference

12 December 2020

Characterization of perimenopausal bone loss: a prospective study

1 reference

12 December 2020

Osteopontin Deficiency Induces Parathyroid Hormone Enhancement of Cortical Bone Formation

1 reference

12 December 2020

Osteopontin in urinary stone formation

1 reference

12 December 2020

Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration

1 reference

12 December 2020

Osteopontin deficiency and aging on nanomechanics of mouse bone.

1 reference

12 December 2020

Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system

1 reference

12 December 2020

The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice

1 reference

12 December 2020

Osteopontin is associated with nuclear factor kappaB gene expression during tail-suspension-induced bone loss.

1 reference

12 December 2020

Staphylococcus aureus induces expression of receptor activator of NF-kappaB ligand and prostaglandin E2 in infected murine osteoblasts

1 reference

12 December 2020

Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro.

1 reference

12 December 2020

Receptor-ligand interaction between CD44 and osteopontin (Eta-1)

1 reference

12 December 2020

Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis

1 reference

12 December 2020

The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway

1 reference

12 December 2020

Parathyroid hormone treatment for osteoporosis

1 reference

12 December 2020

Osteopontin expression in osteoblasts and osteocytes during bone formation under mechanical stress in the calvarial suture in vivo.

1 reference

12 December 2020

Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.

1 reference

12 December 2020

Role of two mineral-associated adhesion molecules, osteopontin and bone sialoprotein, during cementogenesis

1 reference

12 December 2020

Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin

1 reference

12 December 2020

Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation

1 reference

12 December 2020

An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis

1 reference

12 December 2020

Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification

1 reference

12 December 2020

Molecular events caused by mechanical stress in bone

1 reference

12 December 2020

Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio

1 reference

12 December 2020

Ovariectomy-induced bone loss occurs independently of B cells.

1 reference

12 December 2020

Effect of osteoporosis on bone mineral density and fracture repair in a rat femoral fracture model.

1 reference

12 December 2020

Osteopontin at the tumor/host interface. Functional regulation by thrombin-cleavage and consequences for cell adhesion

1 reference

12 December 2020

Curcumin inhibits osteoclastogenesis by decreasing receptor activator of nuclear factor-kappaB ligand (RANKL) in bone marrow stromal cells.

1 reference

12 December 2020

Osteopontin negatively regulates parathyroid hormone receptor signaling in osteoblasts

1 reference

12 December 2020

RANKL, osteopontin, and osteoclast homeostasis in a hyperocclusion mouse model

1 reference

12 December 2020

The pathogenesis of tubulointerstitial disease associated with glomerulonephritis: the glomerular cytokine theory

1 reference

12 December 2020

Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength

1 reference

12 December 2020

Osteopontin facilitates bone resorption, decreasing bone mineral crystallinity and content during calcium deficiency

1 reference

12 December 2020

Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice.

1 reference

12 December 2020

Effects of ovariectomy on bone turnover, porosity, and biomechanical properties in ovine compact bone 12 months postsurgery

1 reference

12 December 2020

Osteopontin expression in cardiovascular diseases

1 reference

12 December 2020

Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone

1 reference

12 December 2020

When should densitometry be repeated in healthy peri- and postmenopausal women: the Danish osteoporosis prevention study

1 reference

12 December 2020

Reconstructing the skeleton with intermittent parathyroid hormone

1 reference

12 December 2020

Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption

1 reference

12 December 2020

Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone

1 reference

12 December 2020

Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival

1 reference

12 December 2020

Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone

1 reference

12 December 2020

Osteopontin as a positive regulator in the osteoclastogenesis of arthritis

1 reference

12 December 2020

Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice

1 reference

12 December 2020

Katz Index of Independence in Activities of Daily Living (ADL)

1 reference

12 December 2020

Osteopontin is required for mechanical stress-dependent signals to bone marrow cells.

1 reference

12 December 2020

Clinical review 123: Anabolic therapy for osteoporosis

1 reference

12 December 2020

Osteopontin function in pathology: lessons from osteopontin-deficient mice.

1 reference

12 December 2020

PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motility

1 reference

12 December 2020

Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84

1 reference

12 December 2020

Bone mineralization and osteoblast differentiation are negatively modulated by integrin alpha(v)beta3.

1 reference

12 December 2020

10.1007/S00198-010-1327-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734029%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference